Bearishness Around Pfizer Gilead Sparks Opportunity
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesWall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
SpaceX shares have tumbled from their peak, trading around $125 as of mid-July 2026. Analysts debate whether the retr...
A new defense funding package faces the glare of lawmakers as the Iran war price tag climbs. The debate centers on ho...
A broad rally in nuclear stocks helped Constellation Energy ride the wave. This piece breaks down the catalysts, what...
Roundhill unveiled plans for a suite of ETFs that would track prediction-market odds on the 2028 U.S. election, signa...
President Donald Trump steps back into the crypto policy debate, accusing banks of blocking progress on GENIUS Act an...
As the Fed signals potential rate cuts, long-duration growth names with strong cash flows could re-rate. This piece f...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
Oil prices are testing a critical threshold as investors weigh potential spillovers to stocks. Some analysts warn the...
Markets brace for Kevin Warsh's first Fed meeting amid stubborn inflation and political scrutiny. Observers ask wheth...
Fresh inflows into ripple (xrp) funds continue despite a broad downturn in crypto ETFs. XRP price remains around $1.1...
As AI-driven stocks wobble between skepticism and momentum, HSBC strategists say a turn in valuations could lift pric...